Literature DB >> 20227354

Determination of methyl-, 2-hydroxyethyl- and 2-cyanoethylmercapturic acids as biomarkers of exposure to alkylating agents in cigarette smoke.

Gerhard Scherer1, Michael Urban, Heinz-Werner Hagedorn, Richard Serafin, Shixia Feng, Sunil Kapur, Raheema Muhammad, Yan Jin, Mohamadi Sarkar, Hans-Juergen Roethig.   

Abstract

Alkylating agents occur in the environment and are formed endogenously. Tobacco smoke contains a variety of alkylating agents or precursors including, among others, N-nitrosodimethylamine (NDMA), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), acrylonitrile and ethylene oxide. We developed and validated a method for the simultaneous determination of methylmercapturic acid (MMA, biomarker for methylating agents such as NDMA and NNK), 2-hydroxyethylmercapturic acid (HEMA, biomarker for ethylene oxide) and 2-cyanoethylmercapturic acid (CEMA, biomarker for acrylonitrile) in human urine using deuterated internal standards of each compound. The method involves liquid/liquid extraction of the urine sample, solid phase extraction on anion exchange cartridges, derivatization with pentafluorobenzyl bromide (PFBBr), liquid/liquid extraction of the reaction mixture and LC-MS/MS analysis with positive electrospray ionization. The method was linear in the ranges of 5.00-600, 1.00-50.0 and 1.50-900 ng/ml for MMA, HEMA and CEMA, respectively. The method was applied to two clinical studies in adult smokers of conventional cigarettes who either continued smoking conventional cigarettes, were switched to test cigarettes consisting of either an electrically heated cigarette smoking system (EHCSS) or having a highly activated carbon granule filter that were shown to have reduced exposure to specific smoke constituents, or stopped smoking. Urinary excretion of MMA was found to be unaffected by switching to the test cigarettes or stop smoking. Urinary HEMA excretion decreased by 46 to 54% after switching to test cigarettes and by approximately 74% when stopping smoking. Urinary CEMA excretion decreased by 74-77% when switching to test cigarettes and by approximately 90% when stopping smoking. This validated method for urinary alkylmercapturic acids is suitable to distinguish differences in exposure not only between smokers and nonsmokers but also between smoking of conventional and the two test cigarettes investigated in this study.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20227354     DOI: 10.1016/j.jchromb.2010.02.023

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  10 in total

Review 1.  Mercapturic acids: recent advances in their determination by liquid chromatography/mass spectrometry and their use in toxicant metabolism studies and in occupational and environmental exposure studies.

Authors:  Patricia I Mathias; Clayton B'hymer
Journal:  Biomarkers       Date:  2016-02-22       Impact factor: 2.658

Review 2.  Biomarkers of exposure to new and emerging tobacco delivery products.

Authors:  Suzaynn F Schick; Benjamin C Blount; Peyton Jacob; Najat A Saliba; John T Bernert; Ahmad El Hellani; Peter Jatlow; R Steven Pappas; Lanqing Wang; Jonathan Foulds; Arunava Ghosh; Stephen S Hecht; John C Gomez; Jessica R Martin; Clementina Mesaros; Sanjay Srivastava; Gideon St Helen; Robert Tarran; Pawel K Lorkiewicz; Ian A Blair; Heather L Kimmel; Claire M Doerschuk; Neal L Benowitz; Aruni Bhatnagar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-18       Impact factor: 5.464

3.  Methyl DNA phosphate adduct formation in lung tumor tissue and adjacent normal tissue of lung cancer patients.

Authors:  Bin Ma; Peter W Villalta; J Bradley Hochalter; Irina Stepanov; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2019-11-25       Impact factor: 4.944

Review 4.  A survey of liquid chromatographic-mass spectrometric analysis of mercapturic acid biomarkers in occupational and environmental exposure monitoring.

Authors:  Patricia I Mathias; Clayton B'Hymer
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-03-12       Impact factor: 3.205

5.  Urinary Cyanoethyl Mercapturic Acid, a Biomarker of the Smoke Toxicant Acrylonitrile, Clearly Distinguishes Smokers From Nonsmokers.

Authors:  Xianghua Luo; Steven G Carmella; Menglan Chen; Joni A Jensen; Lynne R Wilkens; Loic Le Marchand; Dorothy K Hatsukami; Sharon E Murphy; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2020-10-08       Impact factor: 4.244

6.  Urinary excretion of the acrylonitrile metabolite 2-cyanoethylmercapturic acid is correlated with a variety of biomarkers of tobacco smoke exposure and consumption.

Authors:  Emmanuel Minet; Francis Cheung; Graham Errington; Katharina Sterz; Gerhard Scherer
Journal:  Biomarkers       Date:  2010-11-25       Impact factor: 2.658

7.  Urinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approach.

Authors:  Evan O Gregg; Emmanuel Minet; Michael McEwan
Journal:  Biomarkers       Date:  2013-07-31       Impact factor: 2.658

8.  Menthol's potential effects on nicotine dependence: a tobacco industry perspective.

Authors:  Valerie B Yerger
Journal:  Tob Control       Date:  2011-05       Impact factor: 6.953

9.  Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 2. Biomarkers of exposure.

Authors:  Michael W Ogden; Kristin M Marano; Bobbette A Jones; Walter T Morgan; Mitchell F Stiles
Journal:  Biomarkers       Date:  2015-11-10       Impact factor: 2.658

10.  Longitudinal stability in cigarette smokers of urinary biomarkers of exposure to the toxicants acrylonitrile and acrolein.

Authors:  Menglan Chen; Steven G Carmella; Chistopher Sipe; Joni Jensen; Xianghua Luo; Chap T Le; Sharon E Murphy; Neal L Benowitz; F Joseph McClernon; Ryan Vandrey; Sharon S Allen; Rachel Denlinger-Apte; Paul M Cinciripini; Andrew A Strasser; Mustafa al'Absi; Jason D Robinson; Eric C Donny; Dorothy Hatsukami; Stephen S Hecht
Journal:  PLoS One       Date:  2019-01-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.